Cargando…
Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression
Triple negative breast cancer (TNBC) is non-responsive to conventional anti-hormonal and Her2-targeted therapies, making it necessary to identify new molecular targets for therapy. Long non-coding RNA anti-differentiation ncRNA (lncRNA DANCR) was identified participating in carcinogenesis of hepatoc...
Autores principales: | Sha, Sha, Yuan, Dongya, Liu, Yuejun, Han, Baosan, Zhong, Nanbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612229/ https://www.ncbi.nlm.nih.gov/pubmed/28760736 http://dx.doi.org/10.1242/bio.023135 |
Ejemplares similares
-
Long Non-coding RNA DANCR in Cancer: Roles, Mechanisms, and Implications
por: Wang, Maoye, et al.
Publicado: (2021) -
Long non-coding RNA DANCR promotes the progression of non-small-cell lung cancer by inhibiting p21 expression
por: Guo, Lanfang, et al.
Publicado: (2018) -
Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers
por: Jin, Shi-Jia, et al.
Publicado: (2019) -
LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression
por: Tao, Weiyang, et al.
Publicado: (2019) -
High serum exosomal long non‐coding RNA DANCR expression confers poor prognosis in patients with breast cancer
por: Shi, Wenbiao, et al.
Publicado: (2022)